Prostaglandin D2 metabolites as a biomarker of in vivo mast cell activation in systemic mastocytosis and rheumatoid arthritis.

Immun Inflamm Dis · 2016 · PMC4768064 · PMID 27042302

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

did not reach statistical significancep = 0.075so close (0.05 < p ≤ 0.1)

Patients taking NSAIDs, whether with RA ( n = 6), or with SM ( n = 3) had lower T‐PGDM excretion than those who were not ( n = 54 and 14, respectively), however the differences did not reach statistical significance (20.4 vs. 33.5 ng/mg Cr, p = 0.075 for RA patients and 26.3 vs. 58.2 ng/mg Cr, p = 0.064 for SM patients).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.